摘要:
The invention provides the use of a compound of formula (I) or a metal chelate or salt thereof in the manufacture of a therapeutic agent for use in the treatment or prophylaxis of conditions resulting from the presence of free radicals in the human or non-human animal body (wherein in formula (I): each R1 independently represents hydrogen or -CH¿2?COR?5; R5¿ represents hydroxy, optionally hydroxylated alkoxy, amino or alkylamido; each R2 independently represents a group XYR6; X represents a bond, or a C¿1-3? alkylene or oxoalkylene group optionally substituted by a group R?7¿; Y represents a bond, an oxygen atom or a group NR6; R6 is a hydrogen atom, a group COOR8, an alkyl, alkenyl, cycloalkyl, aryl or aralkyl group optionally substituted by one or more groups selected from COOR?8, CONR8¿2, NR82, OR8, =NR8, =O, OP(O) (OR8)R7 and OSO¿3M; R?7 is hydroxy, an optionally hydroxylated, optionally alkoxylated alkyl or aminoalkyl group; R8 is a hydrogen atom or an optionally hydroxylated, optionally alkoxylated alkyl group; M is a hydrogen atom or one equivalent of a physiologically tolerable cation; R3 represents a C¿1-8? alkylene group, a 1,2-cycloalkylene group, or a 1,2-arylene group; and each R?4¿ independently represents hydrogen or C¿1-3? alkyl). Such compounds are particularly effective in relieving symptoms associated with reperfusion of ischemic tissue and in treating or preventing radiation-induced injury.
摘要:
The invention provides iodinated bis phenyl compounds, useful as X-ray contrast agents, of formula (I) (wherein each C6R5 moiety may be the same or different; each R denotes a hydrogen or iodine atom or a group M, two or three non-adjacent R groups on each C6R5 moiety denoting iodine atoms and one, two or three R groups on each C6R5 moiety denoting M groups; X denotes a group providing a 1, 2 or 3 atom chain linking the two C6R5 groups, preferably where X is or contains in the bridging chain a carbonyloxy group each C6R5 group being a triodophenyl group or a group in which each R is other than hydrogen; and each M is independently a non-ionic hydrophilic moiety, M preferably being a non-ionic hydrophilic moiety comprising a monohydroxy- or polyhydroxy-alkyl group) and isomers, especially stereoisomers and rotamers, thereof.
摘要:
The invention relates to MR contrast media containing composite nanoparticles, preferably comprising a superparamagnetic iron oxide core provided with a coating comprising an oxidatively cleaved starch coating optionally together with a functionalized polyalkyleneoxide which serves to prolong blood residence.
摘要:
The present invention provides a polyethylene glycol (PEG) ester surfactant comprising at least one polyethylene glycol moiety and at least one fatty acyl moiety characterised in that said moieties are linked by a linkage incorporating a biodegradable methylene diester unit of formula (I) -CO.O.C(R 1 )(R 2 ).O.CO- (I) where R 1 and R 2 may, for example, each be a hydrogen atom or a monovalent organic group attached through a carbon atom or R 1 and R 2 together may, for example, form a divalent organic group attached through carbon atoms.
摘要:
Novel compounds of general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.
摘要:
The present invention relates to compounds comprising the amino acid sequences of the formulae (IA): -CVNENGGCEQYCSD-, (IB): -FCLPAFEGRNCE- and/or (IC): -RCHEGYSLLADGVSCT- as well as peptide fragments thereof, esters, amides, salts and cyclic derivatives thereof, functional analogues thereof and extended peptide chains carrying amino acids or peptides at the termini of the above sequences or fragments, for use in the prevention or inhibition of binding of tissue factor to FVII.
摘要:
The present invention provides a polyethylene glycol (PEG) ester surfactant comprising at least one polyethylene glycol moiety and at least one fatty acyl moiety characterised in that said moieties are linked by a linkage incorporating a biodegradable methylene diester unit of formula (I)
-CO.O.C(R 1 )(R 2 ).O.CO- (I)
where R 1 and R 2 may, for example, each be a hydrogen atom or a monovalent organic group attached through a carbon atom or R 1 and R 2 together may, for example, form a divalent organic group attached through carbon atoms.
摘要:
Diagnostic contrast agents having microbubbles of gas or a gas precursor stabilised by one or more membrane-forming lipids crosslinked or polymerised in the hydrophilic portion thereof may exhibit high degrees of stability and contrast efficacy.